Keytruda Iv Infusionluk Solution Iceren Vial

In the relentless battle against cancer, the medical community has witnessed a paradigm shift with the advent of immunotherapy. At the forefront of this revolutionary approach stands Keytruda (Pembrolizumab), a groundbreaking medication that harnesses the body’s own immune system to combat various forms of malignancy. Developed by the pharmaceutical giant Merck & Co., Keytruda has…

Dosage form

Pack size


100 Mg/4Ml



Generic Name (Ingredient)

Each mL of concentrate contains 25 mg of Pembrolizumab.

Assuming your emergency circumstances for this product, visit Urgent Quotation page. Besides, for any pharmaceutical questions, please ask us in the comments section.


Keytruda Mechanism of Action

Keytruda belongs to a class of drugs known as monoclonal antibodies, specifically targeting the programmed cell death-1 (PD-1) receptor. This receptor plays a crucial role in regulating the immune system’s response to cancer cells. By blocking the interaction between PD-1 and its ligands, PD-L1 and PD-L2, Keytruda effectively removes the brakes on the immune system, allowing it to recognize and eradicate cancer cells more effectively.

This innovative mechanism of action represents a paradigm shift in cancer treatment, as it empowers the body’s own defenses to combat the disease, rather than relying solely on traditional methods such as chemotherapy or radiation therapy. By harnessing the immune system’s inherent ability to identify and eliminate abnormal cells, Keytruda offers a targeted and personalized approach to cancer treatment.

Indications and Approved Uses

Keytruda has received approval from regulatory authorities for the treatment of numerous cancer types, reflecting its versatility and efficacy in combating various forms of malignancy. These indications include, but are not limited to:

Melanoma: A type of skin cancer that can be aggressive and life-threatening.
Non-small cell lung cancer (NSCLC): One of the most common and deadly forms of lung cancer.
Head and neck squamous cell carcinoma (HNSCC): A type of cancer that affects the lining of the mouth, nose, and throat.
Classical Hodgkin lymphoma: A form of cancer that originates in the lymphatic system.
Primary mediastinal large B-cell lymphoma: A rare type of non-Hodgkin lymphoma.
Cancers of the kidney, bladder, and urinary tract: Malignancies affecting the organs involved in the production and excretion of urine.
Colorectal cancer: Cancer that affects the colon and rectum.
Liver cancer: A potentially life-threatening cancer that originates in the liver.
Triple-negative breast cancer: An aggressive form of breast cancer that lacks receptors for estrogen, progesterone, and HER2.
Cervical and uterine cancers: Malignancies affecting the female reproductive system.
Microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) solid tumors: Cancers with specific genetic mutations that can be targeted by Keytruda.
Tumor mutational burden-high (TMB-H) cancers: Cancers with a high number of genetic mutations, which may make them more susceptible to immunotherapy.
Advanced stomach or esophageal cancers: Cancers affecting the digestive system.
Locally advanced or metastatic biliary tract cancer (BTC): A rare and aggressive form of cancer affecting the bile ducts.
Locally advanced or metastatic human epidermal growth factor receptor 2 (HER2)-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma: Cancers of the stomach or the junction between the stomach and esophagus that lack the HER2 receptor.

This extensive list of indications underscores the versatility and efficacy of Keytruda in combating various forms of cancer, offering hope to patients across a broad spectrum of malignancies.


Dosage and Administration

Keytruda is administered as an intravenous infusion over 30 minutes, with the dosage varying depending on the type and stage of cancer. The recommended dosage can range from 200 mg every 3 weeks to 400 mg every 6 weeks, until disease progression or unacceptable toxicity occurs. It is crucial to follow the healthcare provider’s instructions and adhere to the prescribed dosage regimen to ensure optimal efficacy and minimize potential side effects.

The selection of patients for treatment with Keytruda is based on specific criteria, such as the presence of positive PD-L1 expression in various stages and types of cancers, or the presence of specific genetic markers like microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) status in tumor specimens. For the tumor mutational burden-high (TMB-H) indication, patients are selected based on the TMB-H status in their tumor specimens.

Side Effects and Precautions

Like any potent medication, Keytruda carries the risk of side effects, some of which can be severe or life-threatening.

Common side effects may include:

  • Diarrhea
  • Fatigue
  • Loss of appetite
  • Nausea
  • Itchy skin
  • Rash

More serious adverse reactions can occur, such as:

  • Lung problems
    • Cough
    • Shortness of breath
    • Chest pain
  • Intestinal issues
    • Diarrhea
    • Severe stomach pain or tenderness
  • Liver dysfunction
    • Yellowing of skin or eyes
    • Severe nausea or vomiting
  • Kidney problems
    • Decreased urine output
    • Blood in urine
  • Skin problems
    • Rash
    • Blistering
    • Peeling
  • Hormone gland problems
    • Headaches
    • Rapid heartbeat
    • Weight changes
    • Constipation
    • Hair loss

Patients should be vigilant for any new or worsening symptoms and promptly report them to their healthcare provider. Additionally, caution is advised in patients with immune system disorders, as Keytruda can potentially cause the immune system to attack normal organs and tissues, a condition known as immune-related adverse events (irAEs).

Keytruda: At a glance

Aspect Details
Composition Keytruda is a concentrate for solution for infusion, containing 25 mg of Pembrolizumab per mL.
Mechanism of Action Blocks the interaction between the PD-1 receptor and its ligands, allowing the immune system to target and eliminate cancer cells more effectively.
Indications Approved for various cancers, including melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, stomach cancer, cervical cancer, and certain types of breast cancer, among others.
Dosage Form Injection, powder, lyophilized, for solution.
Administration Intravenous infusion over 30 minutes.
Dosage Guidelines Varies depending on cancer type and stage, ranging from 200 mg every 3 weeks to 400 mg every 6 weeks.
Common Side Effects Diarrhea, fatigue, loss of appetite, nausea, itchy skin, rash.
Serious Side Effects Lung problems, intestinal issues, liver or kidney dysfunction, skin problems, hormone gland problems.
Contraindications No specific contraindications, but caution advised in patients with immune system disorders.
Pregnancy and Lactation Can cause fetal harm; not recommended during pregnancy or breastfeeding.
Drug Interactions Potential interactions with corticosteroids, immunosuppressants, and other medications.

In the ever-evolving landscape of cancer treatment, Keytruda stands as a beacon of hope, offering a targeted and personalized approach to combating malignancies. As research continues to unravel the complexities of cancer immunotherapy, Keytruda remains at the forefront, providing a powerful tool in the fight against this formidable disease.

However, it is crucial to understand that Keytruda is not a one-size-fits-all solution, and its use must be carefully evaluated and monitored by healthcare professionals. Patients should engage in open and honest discussions with their healthcare providers, weighing the potential benefits against the risks and considering their individual circumstances.

The journey towards a cancer-free future is paved with challenges, but with groundbreaking advancements like Keytruda, the medical community is better equipped than ever before to confront this formidable foe. As research continues to unravel the intricacies of cancer immunotherapy, the future holds promise for even more targeted and effective treatments, offering hope and renewed vigor to those battling this devastating disease.


There are no reviews yet.

Be the first to review “Keytruda Iv Infusionluk Solution Iceren Vial”

Your email address will not be published. Required fields are marked *

Use the form below to report an error

Please answer the questions as thoroughly and accurately as possible. Your answers will help us better understand what kind of mistakes happen, why and where they happen, and in the end the purpose is to build a better archive to guide researchers and professionals around the world.

If an image of the drug is not available on the Wikikenko health encyclopedia, you have the option to submit images/leaflets of the product. Following verification by our pharmaceutical specialist, your submitted images/leaflets will be included in our archive, with due acknowledgment of your contribution. Your cooperation in this matter would greatly assist researchers in finding the information they seek. Upload Images/Leaflet (Less than 2MB)

No Choosen File
(Max 2 MB)

The information on this page is not intended to be a substitute for professional medical advice, diagnosis, or treatment. always seek the advice for your physician or another qualified health provider with any questions you may have regarding a medical condition. Always remember to

  1. Ask your own doctor for medical advice.
  2. Names, brands, and dosage may differ between countries.
  3. When not feeling well, or experiencing side effects always contact your own doctor.


The truth is that when we’re sick, or worried about getting sick, the internet won’t help.

According to Wikipedia, cyberchondria is a mental disorder consisting in the desire to independently make a diagnosis based on the symptoms of diseases described on Internet sites.

Why you can't look for symptoms on the Internet

If diagnoses could be made simply from a textbook or an article on a website, we would all be doctors and treat ourselves. Nothing can replace the experience and knowledge of specially trained people. As in any field, in medicine there are unscrupulous specialists, differences of opinion, inaccurate diagnoses and incorrect test results.


People also search for…

More results…

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

The expert search feature is especially useful for healthcare professionals, researchers, and scientists who require accurate and up-to-date information on pharmaceutical products. By narrowing down their searches using filters, they can easily access the relevant data they need, making informed decisions about treatment options or drug research endeavors.

Expert Search  →

Recent comments